DyGenEpi: Gender Dysphoria: Epidemiological Data

• Sponsor: Central Hospital, Nancy, France (Other)
• Overall Status: Unknown status
• CT.gov ID: NCT04573127
• Collaborator: (none)
• Enrollment: 320
• Location: 1
• Anticipated Duration (Months): 15.2
• Patients Per Site Per Month: 21.1

Study Details

Study Description

Brief Summary

Retrospective study in a single academic regional transgender referral center. data from the cohort follow-up in CHRU de Nancy

Condition or Disease	Intervention/Treatment	Phase
Gender Dysphoria	Other: descriptive study

Study Design

• Study Type: Observational
• Anticipated Enrollment: 320 participants
• Observational Model: Cohort
• Time Perspective: Retrospective
• Official Title: Epidemiological Characteristics of the Population of Persons With Gender Dysphoria : Data From the Cohort Follow-up in CHRU de Nancy
• Actual Study Start Date: Jul 27, 2020
• Anticipated Primary Completion Date: Nov 1, 2021
• Anticipated Study Completion Date: Nov 1, 2021

Outcome Measures

Primary Outcome Measures

1. Incdience rate of cardiovascular diseases [2004-2020]

   Number of new cases of arterial hypertension, stroke, myocardial infarction during the specified period (2004-2020) /Time each person was observed, totaled for all persons

2. Incidence rate of dyslipidemia [2004-2020]

   Number of new cases of dyslipidemia during the specified period (2004-2020) /Time each person was observed, totaled for all persons

Secondary Outcome Measures

1. Incidence rate of oncological diseases [2004-2020]

   Number of new cases of malignancies during the specified period (2004-2020) /Time each person was observed, totaled for all persons

2. Incidence rate of psychiatric diseases [2004-2020]

   Number of new cases of psychiatric diseases malignancies during the specified period (2004-2020) /Time each person was observed, totaled for all persons

3. Overall mortality rate [2004-2020]

   Mortality during the specified period (2004-2020) /Time each person was observed, totaled for all persons

Eligibility Criteria

Criteria

• Ages Eligible for Study: N/A and Older
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: No

Retrospective analysis of available data as a part of the regular care of subjects with gender dysphoria. All measurements were made at the time of the routine follow-up visits

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	CHRU Nancy	Nancy		France	54000

Sponsors and Collaborators

• Central Hospital, Nancy, France

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: Central Hospital, Nancy, France
• ClinicalTrials.gov Identifier: NCT04573127
• Other Study ID Numbers: 2020PI159
• First Posted: Oct 5, 2020
• Last Update Posted: Oct 5, 2020
• Last Verified: Jul 1, 2020

• Individual Participant Data (IPD) Sharing Statement: Undecided
• Plan to Share IPD: Undecided
• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No
• Additional relevant MeSH terms: Depressive Disorder, Major; Gender Dysphoria

Study Results

No Results Posted as of Oct 5, 2020